Closed
SectorHealthcare
4.49 5.65
24h
Min
4.25
Max
4.62
Income | -11M -46M |
---|---|
Sales | -815K 4.2M |
Profit margin | -1,077.237 |
Employees | 596 |
EBITDA | 16M -40M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +87.11% upside |
Next Earnings | 3 Nov 2025 |
---|
Market Cap | 681M 1.3B |
---|---|
Previous open | -1.16 |
Previous close | 4.49 |
By Acuity
34%
66%
95 / 374 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 8.42 USD 87.11%
High 17 USD
Low 4.5 USD
Based on 7 Wall Street analysts offering 12 month price targets forAbCellera Biologics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$